Viewing Study NCT07223203

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:48 PM
Ignite Modification Date: 2026-02-12 @ 2:42 AM
Study NCT ID: NCT07223203
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-22
First Post: 2025-10-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
Sponsor: Alnylam Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy View
None hATTR-PN View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Polyneuropathy View
None Amyloidosis View
None Transthyretin View
None TTR View
None RNAi therapeutic View